f Multicentric Reticulohistiocytosis: Clinical Insights, Diagnostic Challenges and Therapeutic Approaches

References

1. KaulA. TolatS. BelgaumkarV. MhaskeC. Multicentric reticulohistiocytosis.Indian J. Dermatol. Venereol. Leprol.201076440440710.4103/0378‑6323.66598 20657124
   [Google Scholar]
2. JainH. VasdevV. SivasamiK. Multicentric reticulohistiocytosis.QJM202411752252310.1093/qjmed/hcae037
   [Google Scholar]
3. Alpay KanitezN. ÇelikS. BesC. Polyarthritis and its differential diagnosis.Eur. J. Rheumatol.20196416717310.5152/eurjrheum.2019.19145 31657698
   [Google Scholar]
4. TozB. BüyükbabaniN. İnançM. Multicentric reticulohistiocytosis: Rheumatology perspective.Best Pract. Res. Clin. Rheumatol.201630225026010.1016/j.berh.2016.07.002 27886798
   [Google Scholar]
5. TasF. ErturkK. Elevated erythrocyte sedimentation rate is associated with metastatic disease and worse survival in patients with cutaneous malignant melanoma.Mol. Clin. Oncol.2017761142114610.3892/mco.2017.1440 29285390
   [Google Scholar]
6. de LeonD. ChiuY. CoD. SokumbiO. Multicentric reticulohistiocytosis in a 5-year-old girl.J. Pediatr.2016177328328.e110.1016/j.jpeds.2016.06.090 27492868
   [Google Scholar]
7. XuX.L. LiangX.H. LiuJ. DengX. ZhangL. WangZ.G. Multicentric reticulohistiocytosis with prominent skin lesions and arthritis: A case report.World J. Clin. Cases202210227913792310.12998/wjcc.v10.i22.7913 36158473
   [Google Scholar]
8. MoriM. NarutoT. ImagawaT. Methotrexate for the treatment of juvenile idiopathic arthritis: Process to approval for JIA indication in Japan.Mod. Rheumatol.200919111110.3109/s10165‑008‑0123‑3 18815725
   [Google Scholar]
9. TariqS. HugenbergS.T. Hirano-AliS.A. TariqH. Multicentric reticulohistiocytosis (MRH): Case report with review of literature between 1991 and 2014 with in depth analysis of various treatment regimens and outcomes.Springerplus20165118010.1186/s40064‑016‑1874‑5 27026876
   [Google Scholar]
10. ChesneR.B. DoorninkM.T. Sri-JayanthaL.S.H. UrieB.K. Leflunomide with prednisone or nonsteroidal anti-inflammatory drug therapy is safe and tolerated for long-term treatment of immune-mediated polyarthritis in 27 dogs.J. Am. Vet. Med. Assoc.202426291188119210.2460/javma.24.01.0032 38608652
    [Google Scholar]
11. KastratiK. AletahaD. BurmesterG.R. A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases.RMD Open202282e00235910.1136/rmdopen‑2022‑002359 36260501
    [Google Scholar]
12. Serrano SerraJ.P. Ruiz MartínezJ. Orts PacoJ.F. Multicentric reticulohistiocytosis with good response to tocilizumab.Med. Clín. (Barc.)20241631263663710.1016/j.medcli.2024.06.015 39245625
    [Google Scholar]
13. Macía-VillaC.C. Zea-MendozaA. Multicentric reticulohistiocytosis: Case report with response to infliximab and review of treatment options.Clin. Rheumatol.201635252753410.1007/s10067‑014‑2611‑5 24733253
    [Google Scholar]
14. GotoH. InabaM. KobayashiK. Successful treatment of multicentric reticulohistiocytosis with alendronate: Evidence for a direct effect of bisphosphonate on histiocytes.Arthritis Rheum.200348123538354110.1002/art.11362 14674006
    [Google Scholar]
15. Bruscas IzuC. Hörndler ArgarateC. García Latasa de AraníbarF.J. Multicentric reticulohistiocytosis: A case report treated with tofacitinib.Med. Clin. (Barc.)2021156631031110.1016/j.medcli.2019.12.011 32173071
    [Google Scholar]
16. LimK. D’SouzaJ. VasquezJ.B. VuyyuruS. Looks can be deceiving: A case report on multicentric reticulohistiocytosis successfully treated with Rituximab.Cureus201795e122010.7759/cureus.1220 28589069
    [Google Scholar]